DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,054 filers reported holding DANAHER CORPORATION in Q4 2021. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $823,303 | +3.5% | 3,318 | +0.1% | 0.06% | +8.3% |
| Q2 2023 | $795,464 | -4.8% | 3,314 | 0.0% | 0.06% | -7.7% |
| Q1 2023 | $835,370 | -2.4% | 3,314 | +2.8% | 0.06% | -11.0% |
| Q4 2022 | $856,094 | +2.8% | 3,225 | 0.0% | 0.07% | -5.2% |
| Q3 2022 | $833,000 | +5.7% | 3,225 | +3.8% | 0.08% | +10.0% |
| Q2 2022 | $788,000 | -13.8% | 3,108 | -0.3% | 0.07% | -1.4% |
| Q1 2022 | $914,000 | -11.1% | 3,117 | -0.3% | 0.07% | -7.8% |
| Q4 2021 | $1,028,000 | +8.0% | 3,125 | 0.0% | 0.08% | -1.3% |
| Q3 2021 | $952,000 | +13.5% | 3,125 | 0.0% | 0.08% | +13.0% |
| Q2 2021 | $839,000 | +18.7% | 3,125 | -0.5% | 0.07% | +15.0% |
| Q1 2021 | $707,000 | +1.6% | 3,142 | +0.3% | 0.06% | -34.1% |
| Q4 2020 | $696,000 | +5.1% | 3,132 | +1.9% | 0.09% | -38.9% |
| Q3 2020 | $662,000 | +21.7% | 3,074 | 0.0% | 0.15% | +12.0% |
| Q2 2020 | $544,000 | +27.7% | 3,074 | 0.0% | 0.13% | +4.7% |
| Q1 2020 | $426,000 | -10.1% | 3,074 | -0.5% | 0.13% | +14.4% |
| Q4 2019 | $474,000 | +0.6% | 3,088 | -5.2% | 0.11% | -7.5% |
| Q3 2019 | $471,000 | +0.6% | 3,258 | -0.5% | 0.12% | -4.8% |
| Q2 2019 | $468,000 | +8.8% | 3,275 | +0.5% | 0.13% | +4.1% |
| Q1 2019 | $430,000 | +23.6% | 3,258 | -3.3% | 0.12% | +5.2% |
| Q4 2018 | $348,000 | -1.7% | 3,370 | +3.5% | 0.12% | +9.5% |
| Q3 2018 | $354,000 | +10.3% | 3,257 | 0.0% | 0.10% | +1.9% |
| Q2 2018 | $321,000 | +0.6% | 3,257 | +0.0% | 0.10% | -1.0% |
| Q1 2018 | $319,000 | +3.6% | 3,256 | -2.0% | 0.10% | -1.9% |
| Q4 2017 | $308,000 | +8.1% | 3,321 | +0.1% | 0.11% | -2.8% |
| Q3 2017 | $285,000 | -6.6% | 3,319 | -8.2% | 0.11% | -19.3% |
| Q2 2017 | $305,000 | -0.3% | 3,616 | +0.9% | 0.14% | -4.9% |
| Q1 2017 | $306,000 | -0.3% | 3,583 | -9.2% | 0.14% | -8.4% |
| Q4 2016 | $307,000 | +13.7% | 3,945 | +14.4% | 0.16% | +11.5% |
| Q3 2016 | $270,000 | -89.1% | 3,448 | -85.9% | 0.14% | -89.2% |
| Q2 2016 | $2,473,000 | +10.9% | 24,482 | +4.1% | 1.29% | +4.0% |
| Q1 2016 | $2,230,000 | +3.5% | 23,508 | +1.3% | 1.24% | +0.2% |
| Q4 2015 | $2,155,000 | +11.3% | 23,202 | +2.1% | 1.23% | +2.3% |
| Q3 2015 | $1,937,000 | +10.4% | 22,731 | +10.8% | 1.21% | +26.7% |
| Q2 2015 | $1,755,000 | +7.9% | 20,508 | +7.0% | 0.95% | -9.2% |
| Q1 2015 | $1,627,000 | +6.8% | 19,160 | +7.8% | 1.05% | -12.0% |
| Q4 2014 | $1,523,000 | +17.2% | 17,766 | +3.9% | 1.19% | -3.3% |
| Q3 2014 | $1,299,000 | -2.7% | 17,091 | +0.8% | 1.23% | -12.5% |
| Q2 2014 | $1,335,000 | +4.4% | 16,963 | -0.6% | 1.41% | +1.1% |
| Q1 2014 | $1,279,000 | +90.3% | 17,057 | +95.9% | 1.39% | +113.0% |
| Q4 2013 | $672,000 | – | 8,708 | – | 0.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |